✨ Free AI Report
Odonate Therapeutics, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview Odonate Therapeutics, Inc.
Research Preview

Odonate Therapeutics, Inc.: Business Overview, Financials & Competitive Analysis

Odonate Therapeutics was a San Diego-based pharmaceutical company focused on developing tesetaxel, an oral chemotherapy agent for cancer treatment. The company ceased operations in March 2021 after the FDA deemed its ...

Analyst-debate audio for Odonate Therapeutics, Inc.

AskCyborg analysts argue the bull and bear cases for Odonate Therapeutics, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Odonate Therapeutics, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
1/ 10Challenged

Cyborg Score thesis

Ceased-operations biotech with no active pipeline; defunct as of March 2021....

Read the full analyst-debate transcript →
Industry Oncology therapeutics development
2 named competitors
1 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: June 22, 2026
AI-Verified Research
30+ Page Report

Get the Latest Odonate Therapeutics, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Odonate Therapeutics, Inc. Overview

Pro stress-test →

Odonate Therapeutics was a San Diego-based pharmaceutical company focused on developing tesetaxel, an oral chemotherapy agent for cancer treatment. The company ceased operations in March 2021 after the FDA deemed its lead clinical data insufficient for approval.

Strategic Profile

Pro stress-test →

Odonate's strategic focus was on creating a patient-friendly oral alternative to intravenously-administered taxanes with improved quality-of-life outcomes. The company conducted the CONTESSA Phase 3 trial for metastatic breast cancer but failed to generate approvable clinical data.

Competitive Landscape

Pro stress-test →

Odonate competed in the oral chemotherapy space against established taxane producers (Hospira/Pfizer for Taxol/paclitaxel, Sanofi for Taxotere/docetaxel) and emerging oral chemotherapy developers. However, competitive positioning is moot given the company's closure.

Industry Context

Odonate Therapeutics, Inc. operates in Oncology therapeutics development.

Key facts

Founded: 2013 · Headquarters: San Diego, US · Employees: 153 · Revenue: $28.2M · Market cap: N/A

What the analysts stress-tested

The top findings that survived the multi-agent debate for Odonate Therapeutics, Inc..

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Odonate Therapeutics, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Taxol/PaclitaxelIV taxane chemotherapy (gold standard)→Taxotere/DocetaxelIV taxane chemotherapy→

Compare Odonate Therapeutics, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Odonate Therapeutics, Inc. operates in Oncology therapeutics development. See how the rest of the sector scores on the Cyborg framework.

Browse Oncology therapeutics development research →
NEW · MCP server

Ask your AI assistant about Odonate Therapeutics, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Odonate Therapeutics, Inc. and its top competitor on Cyborg Score”
“What did Odonate Therapeutics, Inc. do this quarter?”
“Is Odonate Therapeutics, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Odonate Therapeutics, Inc. do?+
Odonate Therapeutics was a San Diego-based pharmaceutical company focused on developing tesetaxel, an oral chemotherapy agent for cancer treatment. The company ceased operations in March 2021 after the FDA deemed its ...
What is Odonate Therapeutics, Inc.'s Cyborg Score?+
Odonate Therapeutics, Inc. has a Cyborg Score of 1/10 (Challenged). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Odonate Therapeutics, Inc.'s main competitors?+
Named competitors include Taxol/Paclitaxel, Taxotere/Docetaxel. The full competitive landscape is in the AskCyborg report.
How can I get the full Odonate Therapeutics, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Odonate Therapeutics, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Odonate Therapeutics, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

Other strong performers across the analyst-debate framework. Click any to see their research report.

9GELEX Group Joint Stock Company9TTM Technologies, Inc.9Insulet Corporation9Marathon Petroleum Corporation9Seagate Technology Holdings plc9Howmet Aerospace Inc.9Investor AB9Micron Technology, Inc.9Taiwan Semiconductor Manufacturing Company Limited9NVIDIA Corporation8NIO Inc.8Seanergy Maritime Holdings Corp.8Grupo Aeroméxico, S.A.B. de C.V.8Gulf Medical Projects Company8Interloop Limited8Kyverna Therapeutics, Inc.8Tatton Asset Management Plc8Invictus Investment Company PLC